Hetero Drugs
Hetero Drugs is an Indian pharmaceutical company and the world's largest producer of anti-retroviral drugs. Hetero's business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.
Operations
Hetero group employs over 22,000 people. Hetero is a participant in the active pharmaceutical ingredients market and finished dosages. It has marketing presence in over 140 countries.Hetero Group's subsidiaries include Hetero Drugs, Hetero Labs, Hetero Research Foundation, Genx Laboratories and also foreign subsidiaries such as Camber Pharmaceuticals in the United States, Hetero Europe in Europe, Amarox Pharma Global in Indonesia, and Richmond Labs in Argentina. The group is also investing in the wind power industry with a goal to reach 1000 megawatts by 2017.
2009 Swine flu outbreak
In 2009, as the swine flu outbreak was spreading across the globe and various health organizations and government agencies were piling up stocks of Oseltamivir as precautionary measures, Hetero supplied generic Oseltamivir under its brand name Fluvir.Hetero delivered 10 million doses of Oseltamivir to the Indian government in 2009, and shipped about 80 million doses to over 60 countries. Hetero received its second order from Indian government to supply another 10 million doses of Oseltamivir later in 2009.